Clinical Trials Logo

Anxiety Disorder clinical trials

View clinical trials related to Anxiety Disorder.

Filter by:

NCT ID: NCT00252174 Terminated - Cancer Clinical Trials

MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer

Start date: February 2007
Phase: Phase 2
Study type: Interventional

This is a pilot study intended to find out if 3,4-methylenedioxymethamphetamine (MDMA) is safe and can help people with advanced stage cancer and anxiety arising from the cancer diagnosis.

NCT ID: NCT00241397 Completed - Depression Clinical Trials

Study Evaluating Rhapsody Registry in Patients With Depression and Anxiety

Start date: November 2005
Phase: N/A
Study type: Observational

The purpose of this study is to assess the prevalence of Major Depression and/or Anxiety Disorder in patients consulting the General Practitioner with acute or chronic painful physical symptoms and to identify risk factors.

NCT ID: NCT00236015 Completed - Anxiety Disorder Clinical Trials

A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

Start date: November 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of an investigational anti-anxiety medication relative to placebo in patients with generalized anxiety disorder (GAD).

NCT ID: NCT00229281 Completed - Anxiety Disorder Clinical Trials

Short Term Group Therapy for Anxiety Disorder

Start date: February 2004
Phase: N/A
Study type: Interventional

Assessing Anxiety in patient suffering from anxiety disorders (NOT OCD or PTSD)before and after group therapy

NCT ID: NCT00225459 Completed - Anxiety Disorder Clinical Trials

Does Spiritual/Religious Commitment Mediate the Relationship Between Mood Variability and Suicidal Ideation.

Start date: June 2005
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether or not spiritual and/or religious commitment affects mood variability and thoughts of suicide. First we hypothesize that among patients with depressive symptoms, those who have higher religious/spiritual (R/S) commitment will have less suicidal ideation and less mood variability. Second, we hypothesize that higher mood variability will be associated with more suicidal ideation. Finally, dependent on the first two hypotheses, we propose that R/S commitment will mediate the relationship between mood variability and suicidal ideation.

NCT ID: NCT00135525 Completed - Anxiety Disorders Clinical Trials

Study Of Generalized Anxiety Disorder

Start date: May 2003
Phase: Phase 2
Study type: Interventional

This study is designed to evaluate the efficacy and safety in Generalized Anxiety Disorder patients

NCT ID: NCT00122837 Completed - Anxiety Disorder Clinical Trials

A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder

Start date: April 2005
Phase: Phase 3
Study type: Interventional

This is a clinical trial assessing duloxetine and comparator to placebo in patients who have generalized anxiety disorder.

NCT ID: NCT00114374 Terminated - Anxiety Disorder Clinical Trials

SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma Victims

Start date: June 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to examine the efficacy of escitalopram compared to placebo in reducing Acute Stress Disorder (ASD) symptoms and in preventing the emergence of Post-Traumatic Stress Disorder (PTSD) in patients with medical trauma who are at risk for the development of PTSD based on the presence of ASD symptoms.

NCT ID: NCT00114127 Completed - Anxiety Disorder Clinical Trials

Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome

Start date: June 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to examine the safety and efficacy of duloxetine for the treatment of social anxiety disorder.

NCT ID: NCT00113295 Completed - Anxiety Disorder Clinical Trials

Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder

Start date: February 2004
Phase: Phase 4
Study type: Interventional

The purpose of this study is to examine the safety and efficacy of quetiapine for generalized anxiety disorder patients who remain symptomatic despite treatment with paroxetine CR.